Alphatec Holdings, Inc.

ATEC ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $101.7M $120.2M $134.4M $154.6M $204.7M $196.3M $197.7M $171.6M
Cost of Revenue $33.5M $44.1M $46.4M $45.0M $78.7M $70.8M $79.2M $57.7M
Gross Profit $68.2M $76.1M $88.0M $109.7M $124.3M $123.8M $116.9M $112.8M
Gross Margin 67.1% 63.3% 65.5% 70.9% 60.7% 63.1% 59.1% 65.7%
Operating Expenses
Research & Development — — $17.8M $16.8M $14.2M $14.9M $16.9M $16.4M
SG&A Expense $70.0M $26.3M $28.1M $34.0M $47.9M $39.9M $36.4M $31.1M
Operating Income $-9.0M $-15.4M $-175.9M $1.5M $-73.4M $-9.8M $-24.5M $-11.8M
Operating Margin -8.8% -12.8% -130.9% 1.0% -35.9% -5.0% -12.4% -6.9%
Interest Expense — $5.4M $4.0M $3.0M $4.0M $6.1M $3.0M $5.9M
Pretax Income $-4.6M $-30.9M $-172.4M $309.0K $-79.0M $-16.6M $-26.7M $-16.5M
Income Tax Expense $-34.0K $-4.6M $-1.1M $407.0K $3.2M $-1.2M $-4.5M $-2.1M
Net Income $-2.3M $-29.9M $-178.7M $-12.9M $-82.2M $-15.5M $-22.2M $-14.4M
Net Margin -2.3% -24.9% -133.0% -8.3% -40.2% -7.9% -11.2% -8.4%
EPS (Basic) $-0.18 $-1.16 $-7.18 $-0.53 $-0.28 $-0.06 $-0.08 $-0.06
EPS (Diluted) $-1.08 $-1.16 $-7.18 $-0.63 $-0.28 $-0.06 $-0.08 $-0.06
Shares Outstanding (Basic) 12.8M 25.7M 24.9M 24.3M 288.7M 270.7M 266.4M 235.8M
Shares Outstanding (Diluted) 13.3M 25.7M 24.9M 24.4M 288.7M 270.7M 266.4M 235.8M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 3 Older →